David E. Gerber

Also affiliated with Southwestern Medical Center, Southwestern Medical Center, The University of Texas Southwestern Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.466Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lung Cancer Computational Biology and Resources

Cold Spring Harbor Perspectives in Medicine(2021)10.1101/cshperspect.a038273

Top 41%

0.466DataRank

Top 41%9 citations

Guanghua Xiao, David E. Gerber, John D. Minna, Yang Xie, Ling Cai

Papers

Driven by 39 papers — median percentile 59. Top paper: “Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study”.

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

The Lancet Oncology(2023)10.1016/s1470-2045(23)00344-3

N/A

3.1DataRank · unranked

105 citations

Rupesh Kotecha, Rodryg Ramlau, Li Zhang, Janusz Milanowski, Manuel Cobo +20 more

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

New England Journal of Medicine(2015)10.1056/nejmoa1507643

N/A

1.4DataRank · unranked

9414 citations

Luis Paz-Ares, Diane P Holder, David R. Spigel, Martin Steins, Neal E. Ready +38 more

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities

OncoImmunology(2024)10.1080/2162402x.2024.2351255

N/A

0.560DataRank · unranked

10 citations

Mitchell S. von Itzstein, Farjana Fattah, Jialiang Liu, Chengsong Zhu, Yang Xie +6 more

Lung Cancer Computational Biology and Resources

Cold Spring Harbor Perspectives in Medicine(2021)10.1101/cshperspect.a038273

Top 41%

0.466DataRank

Top 41%9 citations

Guanghua Xiao, David E. Gerber, John D. Minna, Yang Xie, Ling Cai

Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG‐ACRIN E2805 trial

Cancer Medicine(2021)10.1002/cam4.4140

N/A

0.315DataRank · unranked

5 citations

Hannah Fullington, David E. Gerber, I. Alex Bowman, Mäneka Puligandla, Janice P. Dutcher +3 more

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)

Therapeutic Advances in Medical Oncology(2024)10.1177/17588359241293401

N/A

0.104DataRank · unranked

1 citations

Megan Othus, Sandip Pravin Patel, David E. Gerber, Tawee Tanvetyanon, Hye Sung Kim +10 more

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9077

N/A

0DataRank · unranked

31 citations

Sumithra J. Mandrekar, Geoffrey R. Oxnard, David Kozono, Shauna L. Hillman, Suzanne E. Dahlberg +13 more

Thyroid dysfunction and immune checkpoint inhibitor outcomes.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e15103

N/A

0DataRank · unranked

1 citations

Rong Lü, Sadia Ali, Donglu Xie, Jennifer Cai, Yang Xie +2 more

Survival among colorectal cancer patients with a history of previous cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16146

N/A

0DataRank · unranked

0 citations

David E. Gerber, Hong Zhu, Daniel F. Heitjan, Bhumika Maddineni, Amit G. Singal +5 more

Survival among breast cancer patients with a history of previous cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e14080

N/A

0DataRank · unranked

0 citations

Hong Zhu, David E. Gerber, Daniel F. Heitjan, Bhumika Maddineni, Danyi Xiong +3 more

Experience, Perceptions, and Recommendations Concerning COVID-19–Related Clinical Research Adjustments

Journal of the National Comprehensive Cancer Network(2021)10.6004/jnccn.2020.7643

N/A

0DataRank · unranked

23 citations

Thomas Sheffield, Muhammad Shaalan Beg, Erin L. Williams, Valerie L. Clark, Yang Xie +4 more

Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer

Cancer Medicine(2021)10.1002/cam4.4036

N/A

0DataRank · unranked

14 citations

David E. Gerber, Hong Zhu, Daniel F. Heitjan, Bhumika Maddineni, Danyi Xiong +5 more

Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids

Nature Communications(2021)10.1038/s41467-021-27276-7

N/A

0DataRank · unranked

14 citations

Gao Guo, Nicole A. Beckley, Xiaoyao Yang, Yue Zhang, David E. Gerber +6 more

Longitudinal Experience With and Impressions of COVID-19–Related Clinical Research Changes

JCO Oncology Practice(2021)10.1200/op.21.00169

N/A

0DataRank · unranked

8 citations

Valerie L. Clark, Thomas Sheffield, Muhammad Shaalan Beg, Yang Xie, M. E. Blair Holbein +4 more

Upfront Brain Treatments Followed by Lung Surgery Improves Survival for Stage IV Non-small Cell Lung Cancer Patients With Brain Metastases: A Large Cohort Analysis

Frontiers in Surgery(2021)10.3389/fsurg.2021.649531

N/A

0DataRank · unranked

5 citations

Yin Shen, Hongyu Liu, Rong Lü, Kemp H. Kernstine, David E. Gerber +3 more

EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation

Nature Cell Biology(2022)10.1038/s41556-022-00962-4

N/A

0DataRank · unranked

42 citations

Ke Gong, Nicole A. Beckley, Yue Zhang, Xiaoyao Yang, Rati Chkheidze +25 more

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.04.012

N/A

0DataRank · unranked

18 citations

Jorge Gómez, Ananda M. Rodilla, Juan Manuel Carreño, Chih–Yuan Hsu, Christian Rolfo +43 more

Prevalence And Impact of Medical Comorbidities in A Real‐World Lung Cancer Screening Population

Clinical Lung Cancer(2022)10.1016/j.cllc.2022.03.009

N/A

0DataRank · unranked

18 citations

Hong Zhu, Sarah A. Williams, Heidi Hamann, Vijaya Subbu Natchimuthu, Jessica L. Lee +12 more

Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy Era

Clinical Lung Cancer(2022)10.1016/j.cllc.2022.09.005

N/A

0DataRank · unranked

10 citations

Mitchell S. von Itzstein, David Hsiehchen, Tri Le, Sawsan Rashdan, Hui Yang +4 more

Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials

Journal of the National Comprehensive Cancer Network(2022)10.6004/jnccn.2022.7017

N/A

0DataRank · unranked

8 citations

Caitlin C. Murphy, Sandi L. Pruitt, Sawsan Rashdan, Asal Rahimi, David E. Gerber +1 more

Placing a Cancer Diagnosis in Clinical Context: Applying Functional Trajectories to Advanced NSCLC

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100366

N/A

0DataRank · unranked

0 citations

David E. Gerber, Heidi Hamann

Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.07.2333

N/A

0DataRank · unranked

10 citations

Puneeth Iyengar, Steven Montalvo, Kenneth D. Westover, Sawsan Rashdan, Kavitha Donthireddy +10 more

Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice

Frontiers in Immunology(2024)10.3389/fimmu.2024.1351739

N/A

0DataRank · unranked

6 citations

Yuqiu Yang, Yiqing Wang, David Hsiehchen, Thomas Sheffield, Farjana Fattah +12 more

Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100751

N/A

0DataRank · unranked

4 citations

Jialiang Liu, Hong Mu-Mosley, Farjana Fattah, Jason Y. Park, Jeffrey A. SoRelle +17 more

Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer

The Oncologist(2024)10.1093/oncolo/oyad335

N/A

0DataRank · unranked

2 citations

Yating Wang, Suresh S. Ramalingam, Sheena Bhalla, Zhuoxin Sun, Hossein Borghaei +3 more

Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care

Cancer(2024)10.1002/cncr.35640

N/A

0DataRank · unranked

1 citations

Tianci Wang, Kathryn Shahan, Vlad G. Zaha, Rachna Goswami, Melanie S. Sulistio +3 more

The Joint Problem of Rheumatoid Arthritis and Lung Cancer

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2023.11.011

N/A

0DataRank · unranked

2 citations

David E. Gerber, Bonnie L. Bermas

Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer

Vaccines(2024)10.3390/vaccines12070713

N/A

0DataRank · unranked

1 citations

Chih–Yuan Hsu, Ananda M. Rodilla, Jorge Gómez, Jazz Cagan, Yuanhui Huang +19 more

Impact of Screening on Mortality for Patients Diagnosed with Hepatocellular Carcinoma in a Safety-Net Healthcare System: An Opportunity for Addressing Disparities

Cancers(2024)10.3390/cancers16223829

N/A

0DataRank · unranked

1 citations

Madison Hull, Kari Teigen, Vedaamrutha Reddy, Jolonda Bullock, Riyaz Basha +4 more

Novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009867

N/A

0DataRank · unranked

9 citations

Manoj K. Sabnani, Laura Gray, Qing Deng, Nusrat U A Saleh, Luc Girard +9 more

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes

Nature Cancer(2025)10.1038/s43018-025-01001-5

N/A

0DataRank · unranked

5 citations

Kaiwen Wang, Saiyang Na, Jia Yao, Farjana Fattah, Alexandra Martin +26 more

Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims data

Frontiers in Oncology(2025)10.3389/fonc.2025.1650373

N/A

0DataRank · unranked

1 citations

David J. Morrell, Regina Grebla, Guy Shechter, David E. Gerber, Benjamin J. Drapkin

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

Lung Cancer(2025)10.1016/j.lungcan.2025.108802

N/A

0DataRank · unranked

1 citations

David E. Gerber, Rupesh Kotecha, Jeffrey P. Ward, Wallace Akerley, Lukas Weiß +5 more

Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

Cancers(2025)10.3390/cancers17213406

N/A

0DataRank · unranked

1 citations

Hui Li, Eman Showkatian, Maliazurina B. Saad, Mohamed Qayati, Sohair Ismail +25 more

EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer

Nature Cancer(2020)10.1038/s43018-020-0048-0

N/A

0DataRank · unranked

95 citations

Gao Guo, Nishah Panchani, Matthew E. Bender, David E. Gerber, John D. Minna +15 more

DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100034

N/A

0DataRank · unranked

75 citations

Antony Hsieh, Robert Samstein, Tianshi Lu, Muhammad Shaalan Beg, David E. Gerber +4 more

A randomized trial of mail and email recruitment strategies for a physician survey on clinical trial accrual

BMC Medical Research Methodology(2020)10.1186/s12874-020-01014-x

N/A

0DataRank · unranked

51 citations

Simon J. Craddock Lee, Ann M. Geiger, John V. Cox, Chul Ahn, Rasmi G. Nair +5 more

Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study

Supportive Care in Cancer(2020)10.1007/s00520-020-05364-6

N/A

0DataRank · unranked

10 citations

Neil Keshvani, Arjun Gupta, Hui Yang, Deepak Agrawal, Tri Le +3 more

Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.02.010

N/A

0DataRank · unranked

6 citations

Heidi Hamann, Claudia Chavez, Olivia Dorsey, Noel Santini, Travis Browning +7 more

David E. Gerber

Indexed papers

Top data-sharing exemplar

Papers